We are actively involved in the development of innovative and complex formulations as we engage with partners throughout the animal health, pharmaceuticals and agri-business industries. We join hands with those who focus on improving the health and wellbeing of animals.
Driven by an expert pool of scientists and researchers, R&D is SeQuent's key growth driver. We have built a comprehensive portfolio of animal health API and animal health formulations as well as human API product basket with continuous research initiatives. Expertise in the development, scale-up
and commercialisation of products involve the following reactions:
- Catalytic hydrogenation (noble metal catalysis)
- Hydride reductions
- Organometallic Reactions (Grignard, diethyl zinc)
- Hazardous reactions involving cyanuric chloride
ethyl mercaptan, and so on
- Asymmetric synthesis and chiral separations
- High pressure and high temperature reactions
- Fluorinations (DAST, deoxyfluor)
- Halogenations
- Azide reactions
- Friedel Crafts reactions
- Suzuki Coupling